Primary Myelofibrosis Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Primary Myelofibrosis stocks.


Compare ETFs

      Primary Myelofibrosis Stocks Recent News

      Date Stock Title
      Primary Myelofibrosis

      Primary myelofibrosis (PMF) is a rare bone marrow blood cancer. It is classified by the World Health Organization (WHO) as a type of myeloproliferative neoplasm, a group of cancers in which there is growth of abnormal cells in the bone marrow. This is most often associated with a somatic mutation in the JAK2, CALR, or MPL gene markers. In PMF, the healthy marrow is replaced by scar tissue (fibrosis), resulting in a lack of production of normal blood cells. Symptoms include anemia, increased infection and an enlarged spleen (splenomegaly).
      In 2016, prefibrotic primary myelofibrosis was formally classified as a distinct condition that progresses to overt PMF in many patients, the primary diagnostic difference being the grade of fibrosis.

      Browse All Tags